The Scientific Basis for the Treatment of Parkinson's Disease
Charles Warren Olanow, Abraham N. Lieberman
Parthenon Publishing Group, 1992 - Medical - 307 pages
An international review of recent methods of treating Parkinson's disease, and the scientific basis on which these methods are based. At the same time, the book covers preventative and grafting treatment.
37 pages matching dose of levodopa in this book
Results 1-3 of 37
What people are saying - Write a review
We haven't found any reviews in the usual places.
Etiology of Parkinsons disease
Adverse effects of levodopa
Neural grafting for Parkinsons disease
4 other sections not shown
activity adrenal chromaffin cells adrenal grafting adrenal medulla adrenal medullary advanced Parkinson's disease antioxidant BDNF bFGF Brain Res bromocriptine Calne caudate nucleus chromaffin cells co-grafts D2 dopamine receptor D2 receptor damage degeneration demonstrated deprenyl disability dopamine agonists dopamine neurons dopamine receptor dopaminergic neurons dose of levodopa drug dyskinesias dystonia efficacy fetal fibers free radicals function glutathione growth factor hypothesis idiopathic parkinsonism implants improvement increased inhibitor iron L-dopa lesions levels levodopa levodopa therapy Lewy bodies lipid peroxidation MAO-B mechanism medulla mesencephalic metabolism mice mitochondrial molecular monkeys monoamine oxidase motor Movement Disorders MPTP MPTP-treated mRNA nervous system Neurochem Neurology Neurosci Neurosurg nigrostriatal normal occur Olanow oxidant stress Parkinson's disease Parkinson's disease patients parkinsonian patients patients with Parkinson's pergolide placebo plasma primates random reactions side-effects striatal dopamine striatum substantia nigra survival symptomatic symptoms TH-immunoreactive tissue toxicity transplantation treatment of Parkinson's tremor trophic effect trophic factors ventral